title: Modulation of the renin-angiotensin system in proteinuric renal disease: are there added benefits?
authors.forename: A J
authors.initials: AJ
authors.lastname: Lewington
authors.forename: M
authors.initials: M
authors.lastname: Arici
authors.forename: K P
authors.initials: KP
authors.lastname: Harris
authors.forename: N J
authors.initials: NJ
authors.lastname: Brunskill
authors.forename: J
authors.initials: J
authors.lastname: Walls
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D011507:Proteinuria / Q000209:etiology*; D011945:Receptors, Angiotensin / Q000187:drug effects*; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D006727:Hormone Antagonists; D011945:Receptors, Angiotensin